Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy

Clinical Cancer Research

Volumn 6, Issue 2, 2000, Pages 381-389

  Koukourakis, Michael I ^a,e   Giatromanolaki, Alexandra ^b   Fountzilas, George ^c   Sivridis, Efthimios ^b   Gatter, Kevin C ^d   Harris, Adrian L ^d  

^a UNIVERSITY OF THESSALY   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e Tumour and Angiogenesis Research Group Iraklion   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CARBOPLATIN; CISPLATIN; METHOTREXATE; THYMIDINE PHOSPHORYLASE;

ANGIOGENESIS; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; HEAD CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIMODALITY CANCER THERAPY; NECK CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR VASCULARIZATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RADIATION TOLERANCE; SURVIVAL RATE; THYMIDINE PHOSPHORYLASE;

EID: 0033952360     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Friedkin, M., and Roberts, D. The enzymatic synthesis of nucleosides. II. Thymidine and related pyrimidine nucleosides. J. Biol. Chem., 207: 257-266, 1954.
2. Zimmerman, M., and Seidenberg, J. Deoxyribosyl transfer. I. Thymidine phosphorylase and nucleoside deoxyribosyltransferase in normal and malignant tissues. J. Biol. Chem., 239: 2618-2621, 1964.
3. Pauly, J. L., Schuller, M. G., Zelcer, A. A., Kirss, T. A., Gore, S. S., and Germain, M. J. Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. J. Natl. Cancer Inst., 58: 1587-1590, 1977.
4. Patterson, A. V., Talbot, D. C., Stratford, I. J., and Harris, A. L. Thymidine phosphorylase moderates thymidine-dependent rescue after exposure to the thymidylate synthase inhibitor ZD1694 (Tomudex) in vitro. Cancer Res., 58: 2737-2740, 1998.
5. Johnston, P. G., Mick, R., Recant, W., Behan, K. A., Dolan, M. E., Ratain, M. J., Beckman, E., Weichselbaum, R. R., Allegra, C. J., and Yokes, E. E. Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer. J. Natl. Cancer Inst., 89: 308-313, 1997.
6. Cheradame, S., Etienne, M. C., Formento, P., Schneider, M., Dassonville, O., Demard, F., and Milano, G. Tumoral-reduced folates and clinical resistance to fluorouracil based treatment in head and neck cancer patients. J. Clin. Oncol., 15: 2604-2610, 1997.
7. Fox, S. B., Engels, K., Comley, M., Whitehouse, R. M., Turley, H., Gatter, K. C., and Harris, A. L. Relationship of elevated tumor thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF. Ann. Oncol., 8: 271-275, 1997.
8. Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., and Heldin, C. H. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature (Lond.), 338: 557-562, 1989.
9. Moghaddam, A., Zhang, H. T., Fan, T. P. D., Hu, D. E., Lees, V. C., Turley, H., Fox, S. B., Gatter, K. C., Harris, A. L., and Bicknell, R. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. USA, 92: 998-1002, 1995.
10. Usuki, K., Saras, J., Waltenberger, J., Miyazono, K., Pierce, G., Thomason. A., and Heldin, C. H. Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem. Biophys. Res. Commun., 184: 1311-1316, 1992.
11. Toi, M., Hoshina, S., Taniguchi, T., Yamamoto, Y., Ishitsuka, H., and Tominaga, T. Vascular endothelial growth factor and platelet derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin. Cancer Res., 1: 961-964, 1995.
12. Koukourakis, M. I., Giatromanolaki, A., Kakolyris, S., O'Byrne, K., Apostolikas, T., Skarlatos, J., Gatter, K. C., and Harris, A. L. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non small cell lung cancer. Impact on tumor neoangiogenesis and survival. Br. J. Cancer, 77: 1696-1703, 1998.
13. Takahashi, Y., Bucana, C. D., Liu, W., Yoneda, J., Kitadai, Y., Clearly, K. R., and Ellis, L. M. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J. Natl. Cancer Inst., 88: 1146-1151, 1996.
14. Mauceri, H. J., Hanna, N. N., Beckett, M. A., Gorski, D. H., Staba, M. J., Stellato, K. A., Bigelow, K., Heimann, R., Gately, S., Dhanabal, M., Soff, G. A., Sukhatme, V. P., Kufe, D. W., and Weichselbaum, R. R. Combined effects of angiostatin and ionizing radiation in antitumor therapy. Nature (Lond.), 394: 287-291, 1998.
15. Giatromanolaki, A., Koukourakis, M. I., Georgoulias, V., Gatter, K. C., Harris, A. L., and Fountzilas, G. Angiogenesis versus response after combined chemo-radiotherapy of squamous cell head and neck cancer. Int. J. Cancer, 80: 810-817, 1999.
16. Giatromanolaki, A., Fountzilas, G., Koukourakis, M. I., Arapandoni, P., Theologi, V., Kakolyris, S., Georgoulias, V., Harris, A. L., and Gatter, K. C. Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation. Clin. Exp. Metastasis, 16: 665-672, 1998.
17. Koukourakis, M. I., Giatromanolaki, A., O'Byrne, K., Comley, M., Whitehouse, R., Talbot, D. C., Gatter, K. C., and Harris, A. L. Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small cell lung cancer. Br. J. Cancer, 4: 477-481, 1997.
18. Fox, S. B., Moghaddam, A., Westwood, M., Turley, H., Bicknell, R., Gatter, K. C., and Harris, A. L. Platelet derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues an immuno-histochemical study. J. Pathol., 176: 183-190, 1995.
19. Parums, D. V., Cordell, J. L., Micklem, K., Heryet, A. R., Gatter, K. C., and Mason, D. Y. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J. Clin. Pathol., 43: 752-757, 1990.
20. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
21. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
22. Cox, D. R. Regression models and life-tables. J. R. Stat. Soc. Ser. B, 34: 187-220, 1972.
23. Weidner, N., and Folkman, J. Tumor vascularity as a prognostic factor in cancer. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Cancer. Principles and Practice of Oncology, Pro-updates, Vol. 11, No. 7. Philadelphia, PA: Lippincott-Raven, 1997.
24. Fujieda, S., Sunaga, H., Tsuzuki, H., Tanaka, N., and Saito, H. Expression of platelet-derived endothelial cell growth factor in oral and oropharyngeal carcinoma. Clin. Cancer Res., 4: 1583-1590, 1998.
25. Metzger, R., Denenberg, K., Leichman, G., Salonga, D., Schwartz, E. L., Wadler, S., Lenz, H. J., Groshen, S., Leichman, L., and Danenberg, P. V. High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. Clin. Cancer Res., 4: 2371-2376, 1998.
26. Fowler, J. F. The phantom of tumor treatment-continually rapid proliferation unmasked. Radiother. Oncol., 22: 156-158, 1991.
27. Withers, H. R., Taylor, J. M. G., and Maciejewski, B. The hazards of accelerated tumor clonogene repopulation during radiotherapy. Acta Oncol., 27: 131-146, 1998.
28. Koukourakis, M. I., Hlouverakis, G., Kosma, L., Skarlatos, J., Damilakis, J., Giatromanolaki, A., and Yannakakis, D. The impact of overall treatment time on the results of radiotherapy for non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys., 34: 315-322, 1996.
29. Thames, H. D., Ruifrok, A. C., Milas, L., Hunter, N., Mason, K. A., Terry N. H., and White, R. A. Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma: downregulation of apoptosis as a possible mechanism. Int. J. Radiat. Oncol. Biol. Phys., 35: 951-962, 1996.
30. Beck-Bornholdt, H. P., Omniczynski, M., Theis, E., Vogler, H., and Wurschmidt, F. Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation. Acta Oncol., 30: 57-63, 1991.
31. Begg, A., Hofland, I., and Kummermehr, J. Tumor cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumors. Eur. J. Cancer, 27: 537-543, 1991.
32. Masiero, L., Figg, W. D., and Kohn, C. New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12. Angiogenesis, 1: 23-35, 1997.
33. Gorski, D. H., Beckett, M. A., Jaskowiak, N. T., Calvin, D. P., Mauceri, H. J., Salloum, R. M., Seetharam, S., Koons, A., Had, D. M., Kufe, D. W., and Weichselbaum, R. R. Blockade of the vascular endothelial growth factor stress response increases the antitumor effect of ionizing radiation. Cancer Res., 59: 3374-3378, 1999.
34. 3dThd and its modulator (1): functional mechanism of the cytotoxicity of TAS-102 effective against FUra-resistant tumors. Proc. Am. Assoc. Cancer Res., 39: 469, 1998.